Tabs
Catherine A. Panozzo, PhD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
David Martin, MD, MPH; Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Inna Dashevsky, MS; Sandra DeLuccia, MPH; Elnara Fazio-Eynullayeva, MA; Katherine Freitas; Judith C. Maro, PhD; Tancy Zhang, MPH; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Robert Busch, MD, MMSc; Stacy Chin, MD; Division of Pulmonary, Allergy, and Rheumatology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Kenneth Quinto, MD, MPH; Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Jianmeng Chen, MD; Yunzhao Ren, MD; Division of Cancer Pharmacology, U.S. Food and Drug Administration, Silver Spring, MD
Efe Eworuke, PhD; Marie Bradley, PhD, MScPH, MPharm; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Sally Seymour, MD; Division of Pulmonary, Allergy, and Rheumatology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Beltsville, MD
Yan Li, PhD; Zhong Wang, PhD; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Rongmei Zhang; Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD